Valuation Update With 7 Day Price Move • 16h
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩479,500, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 144% over the past three years. Major Estimate Revision • Apr 23
Consensus EPS estimates increase by 13% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from ₩69,474 to ₩78,711. Revenue forecast steady at ₩6.83b. Net income forecast to shrink 55% next year vs 62% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩673,000. Share price was steady at ₩557,000 over the past week. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩542,000, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 170% over the past three years. Reported Earnings • Mar 14
Full year 2025 earnings: EPS exceeds analyst expectations Full year 2025 results: EPS: ₩209,201 (up from ₩46,752 in FY 2024). Revenue: ₩6.48t (down 2.6% from FY 2024). Net income: ₩1.54t (up 348% from FY 2024). Profit margin: 24% (up from 5.2% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 11%. Revenue is forecast to grow 3.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Mar 13
Consensus EPS estimates fall by 16% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from ₩82,278 to ₩69,474 per share. Revenue forecast steady at ₩6.82b. Net income forecast to shrink 26% next year vs 52% growth forecast for Chemicals industry in South Korea . Consensus price target up from ₩634,500 to ₩672,000. Share price was steady at ₩539,000 over the past week. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 27% After last week's 27% share price decline to ₩495,000, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 129% over the past three years. Declared Dividend • Feb 13
Dividend increased to ₩14,000 Dividend of ₩14,000 is 56% higher than last year. Ex-date: 26th February 2026 Payment date: 1st January 1970 Dividend yield will be 2.7%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is well covered by both earnings (7% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has decreased over the past 8 years, but has still been somewhat stable with no excessively large reductions to payments. EPS is expected to decline by 72% over the next 2 years. However, it would need to fall by 92% to increase the payout ratio to a potentially unsustainable range. Tillkännagivande • Feb 13
KCC Corporation, Annual General Meeting, Mar 26, 2026 KCC Corporation, Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 344, sapyeong-daero, seocho-gu, seoul South Korea Price Target Changed • Feb 12
Price target increased by 9.0% to ₩582,000 Up from ₩534,000, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₩556,000. Stock is up 104% over the past year. The company is forecast to post earnings per share of ₩188,586 for next year compared to ₩42,230 last year. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩556,000, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 150% over the past three years. Tillkännagivande • Jan 31
KCC Corporation to Report Fiscal Year 2025 Results on Feb 05, 2026 KCC Corporation announced that they will report fiscal year 2025 results on Feb 05, 2026 Major Estimate Revision • Jan 24
Consensus EPS estimates increase by 43% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩131,427 to ₩188,586. Revenue forecast steady at ₩6.49b. Net income forecast to shrink 37% next year vs 52% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩534,000. Share price rose 8.1% to ₩474,500 over the past week. Major Estimate Revision • Jan 09
Consensus EPS estimates increase by 16% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩113,587 to ₩131,427. Revenue forecast steady at ₩6.54b. Net income forecast to shrink 55% next year vs 52% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩524,000. Share price was steady at ₩400,000 over the past week. Major Estimate Revision • Nov 13
Consensus EPS estimates increase by 34%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from ₩6.63b to ₩6.54b. EPS estimate rose from ₩107,216 to ₩143,577. Net income forecast to grow 0.3% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩509,000. Share price was steady at ₩424,000 over the past week. Major Estimate Revision • Oct 23
Consensus EPS estimates increase by 70% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩80,134 to ₩135,945. Revenue forecast steady at ₩6.59b. Net income forecast to shrink 1.3% next year vs 49% growth forecast for Chemicals industry in South Korea . Consensus price target of ₩509,000 unchanged from last update. Share price rose 5.7% to ₩416,000 over the past week. Price Target Changed • Oct 04
Price target increased by 9.5% to ₩509,000 Up from ₩465,000, the current price target is an average from 3 analysts. New target price is 36% above last closing price of ₩374,000. Stock is up 27% over the past year. The company is forecast to post earnings per share of ₩80,134 for next year compared to ₩42,230 last year. Valuation Update With 7 Day Price Move • Sep 25
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩363,000, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 71% over the past three years. New Risk • Aug 23
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 20% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings are forecast to decline by an average of 20% per year for the foreseeable future. Minor Risk Large one-off items impacting financial results. Upcoming Dividend • Jul 23
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 30 July 2025. Payment date: 29 August 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.7%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.4%). Upcoming Dividend • Jun 20
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 07 August 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.2%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.7%). Declared Dividend • May 29
Dividend of ₩1,000 announced Shareholders will receive a dividend of ₩1,000. Ex-date: 27th June 2025 Payment date: 7th August 2025 Dividend yield will be 3.2%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (25% cash payout ratio). The dividend has decreased over the past 7 years, but has still been somewhat stable with no excessively large reductions to payments. Price Target Changed • Apr 22
Price target decreased by 11% to ₩340,000 Down from ₩380,000, the current price target is provided by 1 analyst. New target price is 39% above last closing price of ₩244,000. Stock is down 0.8% over the past year. The company is forecast to post earnings per share of ₩21,650 for next year compared to ₩42,230 last year. Reported Earnings • Mar 19
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: ₩42,230 (up from ₩28,917 in FY 2023). Revenue: ₩6.66t (up 5.9% from FY 2023). Net income: ₩310.6b (up 46% from FY 2023). Profit margin: 4.7% (up from 3.4% in FY 2023). Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 29%. Revenue is forecast to grow 1.3% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Declared Dividend • Feb 13
Dividend of ₩9,000 announced Shareholders will receive a dividend of ₩9,000. Ex-date: 27th February 2025 Payment date: 1st January 1970 Dividend yield will be 3.7%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is well covered by both earnings (13% earnings payout ratio) and cash flows (13% cash payout ratio). The dividend has decreased over the past 10 years, but has still been somewhat stable with no excessively large reductions to payments. EPS is expected to decline by 63% over the next 2 years. However, it would need to fall by 86% to increase the payout ratio to a potentially unsustainable range. Tillkännagivande • Feb 12
KCC Corporation, Annual General Meeting, Mar 26, 2025 KCC Corporation, Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 344, sapyeong-daero, seocho-gu, seoul South Korea New Risk • Dec 19
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 30% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings are forecast to decline by an average of 30% per year for the foreseeable future. Minor Risk Large one-off items impacting financial results. New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. New Risk • Dec 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 30% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings are forecast to decline by an average of 30% per year for the foreseeable future. Minor Risk Large one-off items impacting financial results. New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended June 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩275,000, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 7.0% over the past three years. New Risk • May 20
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 5.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings are forecast to decline by an average of 5.4% per year for the foreseeable future. Minor Risk Large one-off items impacting financial results. Tillkännagivande • May 16
KCC Corporation (KOSE:A002380) completed the acquisition of remaining stake in MPM Holdings Inc. from SJL Partners. KCC Corporation (KOSE:A002380) agreed to acquire remaining stake in MPM Holdings Inc. from SJL Partners on March 28, 2024. After completion of the transaction, KCC Corporation will hold 100% stake in Momentive. The anticipated purchase remains subject to customary closing conditions. KCC Corporation (KOSE:A002380) completed the acquisition of remaining stake in MPM Holdings Inc. from SJL Partners on May 14, 2024. Valuation Update With 7 Day Price Move • May 09
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩285,000, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 7.1% over the past three years. Tillkännagivande • Mar 29
KCC Corporation (KOSE:A002380) agreed to acquire an unknown stake in MPM Holdings Inc. from SJL Partners. KCC Corporation (KOSE:A002380) agreed to acquire an unknown stake in MPM Holdings Inc. from SJL Partners on March 28, 2024. After completion of the transaction, KCC Corporation will hold 100% stake in Momentive. The anticipated purchase remains subject to customary closing conditions. Reported Earnings • Mar 20
Full year 2023 earnings released: EPS: ₩28,917 (vs ₩4,564 in FY 2022) Full year 2023 results: EPS: ₩28,917 (up from ₩4,564 in FY 2022). Revenue: ₩6.29t (down 7.2% from FY 2022). Net income: ₩212.7b (up ₩178.8b from FY 2022). Profit margin: 3.4% (up from 0.5% in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩235,500, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩224,000, the stock trades at a trailing P/E ratio of 46.5x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 76% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩1,000 per share at 3.9% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 10 August 2023. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.9%. Within top quartile of South Korean dividend payers (3.2%). Higher than average of industry peers (1.5%). Reported Earnings • Mar 22
Full year 2022 earnings released: EPS: ₩4,564 (vs ₩5,978 loss in FY 2021) Full year 2022 results: EPS: ₩4,564 (up from ₩5,978 loss in FY 2021). Revenue: ₩6.77t (up 15% from FY 2021). Net income: ₩33.9b (up ₩79.6b from FY 2021). Profit margin: 0.5% (up from net loss in FY 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 21
Upcoming dividend of ₩6,000 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.2%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Upcoming Dividend • Jun 22
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 04 August 2022. The company is not currently making a profit and its cash payout ratio is 89%. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.2%). In line with average of industry peers (2.4%). Tillkännagivande • Feb 25
KCC Corporation (KOSE:A002380) announces an Equity Buyback for KRW 100,000 million worth of its shares. KCC Corporation (KOSE:A002380) announces a share repurchase program. Under the program, the company will repurchase up to KRW 100,000 million worth of its shares pursuant to a contract with Korea Investment & Securities Co., Ltd. The purpose of the program is to improve shareholder value through stock price stabilization. The program will expire on August 29, 2022. As of February 23, 2022, the company had 1,221,501 shares in treasury within scope available for dividend and had 6,817 shares in treasury through other repurchase. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₩296,500, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 9.9% over the past three years. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 23% share price gain to ₩387,500, the stock trades at a trailing P/E ratio of 4.2x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 22% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩5,000 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 28 April 2022. Payout ratio is a comfortable 7.3% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improved over the past week After last week's 17% share price gain to ₩320,500, the stock trades at a trailing P/E ratio of 3.5x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 9.6% over the past three years. Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improved over the past week After last week's 23% share price gain to ₩448,500, the stock trades at a trailing P/E ratio of 4.2x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 17% share price gain to ₩363,000, the stock trades at a trailing P/E ratio of 3.4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 4.4% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩700 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 18 August 2021. Trailing yield: 1.9%. Lower than top quartile of South Korean dividend payers (2.1%). Higher than average of industry peers (1.4%). Valuation Update With 7 Day Price Move • May 11
Investor sentiment improved over the past week After last week's 21% share price gain to ₩368,500, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total loss to shareholders of 4.8% over the past three years. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improved over the past week After last week's 21% share price gain to ₩280,500, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improved over the past week After last week's 15% share price gain to ₩233,500, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 34% over the past three years. Tillkännagivande • Feb 11
KCC Corporation, Annual General Meeting, Mar 29, 2021 KCC Corporation, Annual General Meeting, Mar 29, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Jan 22
New 90-day high: ₩215,000 The company is up 37% from its price of ₩156,500 on 23 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 39% over the same period. Is New 90 Day High Low • Jan 05
New 90-day high: ₩204,500 The company is up 32% from its price of ₩155,000 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 26% over the same period. Is New 90 Day High Low • Dec 11
New 90-day high: ₩177,000 The company is up 18% from its price of ₩149,500 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Nov 05
New 90-day high: ₩162,500 The company is up 19% from its price of ₩136,000 on 07 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. Tillkännagivande • Sep 28
KCC Corporation (KOSE:A002380) agreed to acquire 80% stake in Korea Auto Glass Co., Ltd. (KOSE:A152330) for KRW 1.1 trillion. KCC Corporation (KOSE:A002380) agreed to acquire 80% stake in Korea Auto Glass Co., Ltd. (KOSE:A152330) for KRW 1.1 trillion on September 9, 2020. The exchange ratio is 1: 0.4756743. KCC Corporation (KOSE:A002380) will issue 7.6 million shares. The transaction is subject to shareholders approval. The transaction must get at least two-thirds of the voting rights of attending shareholders and one-third of the total number of issued shares. Transaction is expected to complete on December 2, 2020. 
